Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


16.01.2017

1 AIDS Res Hum Retroviruses
1 J Immunol
6 J Infect Dis
1 J Virol
5 MMWR Morb Mortal Wkly Rep
1 N Engl J Med
2 Pediatr Infect Dis J
1 PLoS Comput Biol
8 PLoS One
18 Vaccine
1 Virology
3 Wkly Epidemiol Rec


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS Res Hum Retroviruses

  1. BORGREN M, Jensen SS, Heyndrickx L, Palm A, et al
    Neutralizing antibody response and antibody-dependent cellular cytotoxicity in HIV-1 infected individuals from Guinea-Bissau and Denmark.
    AIDS Res Hum Retroviruses. 2015.
    PubMed     Text format     Abstract available


    J Immunol

  2. ZIEGLER A, Soldner C, Lienenklaus S, Spanier J, et al
    A New RNA-Based Adjuvant Enhances Virus-Specific Vaccine Responses by Locally Triggering TLR- and RLH-Dependent Effects.
    J Immunol. 2017 Jan 11. pii: 1601129. doi: 10.4049/jimmunol.1601129.
    PubMed     Text format     Abstract available


    J Infect Dis

  3. RESIK S, Tejeda A, Diaz M, Okayasu H, et al
    Boosting Immune Responses Following Fractional-Dose Inactivated Poliovirus Vaccine: A Randomized, Controlled Trial.
    J Infect Dis. 2017 Jan 9. pii: jiw492. doi: 10.1093.
    PubMed     Text format     Abstract available

  4. PIERCE KK, Whitehead SS, Kirkpatrick BD, Grier PL, et al
    A Live Attenuated Chimeric West Nile Virus Vaccine, rWN/DEN4Delta30, Is Well Tolerated and Immunogenic in Flavivirus-Naive Older Adult Volunteers.
    J Infect Dis. 2017;215:52-55.
    PubMed     Text format     Abstract available

  5. WEI M, Meng F, Wang S, Li J, et al
    2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study.
    J Infect Dis. 2017;215:56-63.
    PubMed     Text format     Abstract available

  6. NYOMBAYIRE J, Anzala O, Gazzard B, Karita E, et al
    First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens.
    J Infect Dis. 2017;215:95-104.
    PubMed     Text format     Abstract available

  7. COHEN JI
    Vaccination to Reduce Reactivation of Herpes Simplex Virus 2.
    J Infect Dis. 2017 Jan 11. pii: jix006. doi: 10.1093.
    PubMed     Text format    

  8. DO VA, Biering-Sorensen S, Fisker AB, Bale C, et al
    Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau.
    J Infect Dis. 2017 Jan 10. pii: jiw512. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Virol

  9. KIM SM, Kim YI, Park SJ, Kim EH, et al
    Vaccine efficacy of an inactivated, chimeric HA H9/H5N2 avian influenza virus and its suitability for the marker vaccine strategy.
    J Virol. 2017 Jan 11. pii: JVI.01693-16. doi: 10.1128/JVI.01693.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  10. MORALES M, Tangermann RH, Wassilak SG
    Progress Toward Polio Eradication - Worldwide, 2015-2016.
    MMWR Morb Mortal Wkly Rep. 2016;65:470-3.
    PubMed     Text format     Abstract available

  11. BISWAS HH, Han GS, Wendorf K, Winter K, et al
    Notes from the Field: Outbreak of Serogroup B Meningococcal Disease at a University - California, 2016.
    MMWR Morb Mortal Wkly Rep. 2016;65:520-1.
    PubMed     Text format     Abstract available

  12. HOCH DE
    Notes from the Field: Varicella Outbreak Associated with Riding on a School Bus - Muskegon County, Michigan, 2015.
    MMWR Morb Mortal Wkly Rep. 2016;65:941-2.
    PubMed     Text format     Abstract available

  13. PATEL MK, Gacic-Dobo M, Strebel PM, Dabbagh A, et al
    Progress Toward Regional Measles Elimination - Worldwide, 2000-2015.
    MMWR Morb Mortal Wkly Rep. 2016;65:1228-1233.
    PubMed     Text format     Abstract available

  14. MARIN M, Patel M, Oberste S, Pallansch MA, et al
    Guidance for Assessment of Poliovirus Vaccination Status and Vaccination of Children Who Have Received Poliovirus Vaccine Outside the United States.
    MMWR Morb Mortal Wkly Rep. 2017;66:23-25.
    PubMed     Text format     Abstract available


    N Engl J Med

  15. GASTANADUY PA, Budd J, Fisher N, Redd SB, et al
    A Measles Outbreak in an Underimmunized Amish Community in Ohio.
    N Engl J Med. 2016;375:1343-1354.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  16. RODRIGUEZ MELO FI, Morales JJ, De Los Santos AH, Rivas E, et al
    Immunogenicity and Safety of a Booster Injection of DTap-IPV//Hib (Pentaxim(R)) Administered Concomitantly with Tetravalent Dengue Vaccine in Healthy Toddlers Aged 15 to 18 Months in Mexico: A Randomized Trial.
    Pediatr Infect Dis J. 2017 Jan 6. doi: 10.1097/INF.0000000000001542.
    PubMed     Text format     Abstract available

  17. LI F, Hu Y, Zhou Y, Chen L, et al
    A Randomized Controlled Trial to Evaluate a Potential Hepatitis B Booster Vaccination Strategy Using Combined Hepatitis A and B Vaccine.
    Pediatr Infect Dis J. 2017 Jan 3. doi: 10.1097/INF.0000000000001535.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  18. COFFENG LE, Hermsen CC, Sauerwein RW, de Vlas SJ, et al
    The Power of Malaria Vaccine Trials Using Controlled Human Malaria Infection.
    PLoS Comput Biol. 2017;13:e1005255.
    PubMed     Text format     Abstract available


    PLoS One

  19. SMETANA J, Chlibek R, Hanovcova I, Sosovickova R, et al
    Decreasing Seroprevalence of Measles Antibodies after Vaccination - Possible Gap in Measles Protection in Adults in the Czech Republic.
    PLoS One. 2017;12:e0170257.
    PubMed     Text format     Abstract available

  20. LU D, Qiao Y, Brown NE, Wang J, et al
    Racial and Ethnic Disparities in Influenza Vaccination among Adults with Chronic Medical Conditions Vary by Age in the United States.
    PLoS One. 2017;12:e0169679.
    PubMed     Text format     Abstract available

  21. BAWANKULE R, Singh A, Kumar K, Shetye S, et al
    Does Measles Vaccination Reduce the Risk of Acute Respiratory Infection (ARI) and Diarrhea in Children: A Multi-Country Study?
    PLoS One. 2017;12:e0169713.
    PubMed     Text format     Abstract available

  22. LEE HJ, Lee JY, Park MH, Kim JY, et al
    Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced Diseases.
    PLoS One. 2017;12:e0169139.
    PubMed     Text format     Abstract available

  23. SERRANO M, Elguezabal N, Sevilla IA, Geijo MV, et al
    Tuberculosis Detection in Paratuberculosis Vaccinated Calves: New Alternatives against Interference.
    PLoS One. 2017;12:e0169735.
    PubMed     Text format     Abstract available

  24. DARVISHIAN M, Dijkstra F, van Doorn E, Bijlsma MJ, et al
    Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes.
    PLoS One. 2017;12:e0169528.
    PubMed     Text format     Abstract available

  25. FALKENHORST G, Remschmidt C, Harder T, Hummers-Pradier E, et al
    Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis.
    PLoS One. 2017;12:e0169368.
    PubMed     Text format     Abstract available

  26. HE Y, Sultana I, Takeda K, Reed JL, et al
    Cutaneous Deficiency of Filaggrin and STAT3 Exacerbates Vaccinia Disease In Vivo.
    PLoS One. 2017;12:e0170070.
    PubMed     Text format     Abstract available


    Vaccine

  27. ARSENAULT C, Harper S, Nandi A, Mendoza Rodriguez JM, et al
    Monitoring equity in vaccination coverage: A systematic analysis of demographic and health surveys from 45 Gavi-supported countries.
    Vaccine. 2017 Jan 6. pii: S0264-410X(16)31266.
    PubMed     Text format     Abstract available

  28. WANG Y, Chen T, Lu LL, Wang M, et al
    Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.
    Vaccine. 2017 Jan 6. pii: S0264-410X(16)31296.
    PubMed     Text format     Abstract available

  29. PAINTER JE, Plaster AN, Tjersland DH, Jacobsen KH, et al
    Zika virus knowledge, attitudes, and vaccine interest among university students.
    Vaccine. 2017 Jan 6. pii: S0264-410X(16)31275.
    PubMed     Text format     Abstract available

  30. KUMAR S, Sunagar R, Pham G, Gosselin EJ, et al
    Ex vivo antigen-pulsed PBMCs generate potent and long lasting immunity to infection when administered as a vaccine.
    Vaccine. 2017 Jan 6. pii: S0264-410X(16)31260.
    PubMed     Text format     Abstract available

  31. CHEGE GK, Burgers WA, Muller TL, Gray CM, et al
    DNA-MVA-protein vaccination of rhesus macaques induces HIV-specific immunity in mucosal-associated lymph nodes and functional antibodies.
    Vaccine. 2017 Jan 6. pii: S0264-410X(16)31294.
    PubMed     Text format     Abstract available

  32. CORNICK JE, Tastan Bishop O, Yalcin F, Kiran AM, et al
    The global distribution and diversity of protein vaccine candidate antigens in the highly virulent Streptococcus pnuemoniae serotype 1.
    Vaccine. 2017 Jan 9. pii: S0264-410X(16)31262.
    PubMed     Text format     Abstract available

  33. MORGEAUX S, Poirier B, Ragan CI, Wilkinson D, et al
    Replacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISA - Results of an international collaborative study.
    Vaccine. 2017 Jan 9. pii: S0264-410X(16)31264.
    PubMed     Text format     Abstract available

  34. KAPETANOVIC MC, Nagel J, Nordstrom I, Saxne T, et al
    Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine.
    Vaccine. 2017 Jan 9. pii: S0264-410X(17)30002.
    PubMed     Text format     Abstract available

  35. THARMAPHORNPILAS P, Jiamsiri S, Boonchaiya S, Rochanathimoke O, et al
    Evaluating the first introduction of rotavirus vaccine in Thailand: Moving from evidence to policy.
    Vaccine. 2017 Jan 2. pii: S0264-410X(16)31268.
    PubMed     Text format     Abstract available

  36. YUDIN MH, Mistry N, De Souza LR, Besel K, et al
    Text messages for influenza vaccination among pregnant women: A randomized controlled trial.
    Vaccine. 2017 Jan 3. pii: S0264-410X(16)31195.
    PubMed     Text format     Abstract available

  37. FU LY, Zimet GD, Latkin CA, Joseph JG, et al
    Associations of trust and healthcare provider advice with HPV vaccine acceptance among African American parents.
    Vaccine. 2017 Jan 4. pii: S0264-410X(16)31270.
    PubMed     Text format     Abstract available

  38. SASAKI E, Kuramitsu M, Momose H, Kobiyama K, et al
    A novel vaccinological evaluation of intranasal vaccine and adjuvant safety for preclinical tests.
    Vaccine. 2017 Jan 4. pii: S0264-410X(16)31261.
    PubMed     Text format     Abstract available

  39. CESPEDES PF, Rey-Jurado E, Espinoza JA, Rivera CA, et al
    A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice.
    Vaccine. 2017 Jan 5. pii: S0264-410X(16)31273.
    PubMed     Text format     Abstract available

  40. GESSNER BD, Knobel DL, Conan A, Finn A, et al
    Could the RTS,S/AS01 meningitis safety signal really be a protective effect of rabies vaccine?
    Vaccine. 2017 Jan 5. pii: S0264-410X(17)30001.
    PubMed     Text format     Abstract available

  41. LOWELL GH, Ziv S, Bruzil S, Babecoff R, et al
    Back to the future: Immunization with M-001 prior to trivalent influenza vaccine in 2011/12 enhanced protective immune responses against 2014/15 epidemic strain.
    Vaccine. 2017 Jan 5. pii: S0264-410X(16)31297.
    PubMed     Text format     Abstract available

  42. NEROME K, Matsuda S, Maegawa K, Sugita S, et al
    Quantitative analysis of the yield of avian H7 influenza virus haemagglutinin protein produced in silkworm pupae with the use of the codon-optimized DNA: A possible oral vaccine.
    Vaccine. 2017 Jan 5. pii: S0264-410X(16)31291.
    PubMed     Text format     Abstract available

  43. HEDBERG AL, Pauksens K, Enblad P, Soderberg J, et al
    Pneumococcal polysaccharide vaccination administered early after neurotrauma or neurosurgery.
    Vaccine. 2017 Jan 6. pii: S0264-410X(16)31299.
    PubMed     Text format     Abstract available

  44. GOWTAGE S, Williams GA, Henderson R, Aylett P, et al
    Testing of a palatable bait and compatible vaccine carrier for the oral vaccination of European badgers (Meles meles) against tuberculosis.
    Vaccine. 2017 Jan 9. pii: S0264-410X(16)31198.
    PubMed     Text format     Abstract available


    Virology

  45. GALLAGHER JR, Torian U, McCraw DM, Harris AK, et al
    Characterization of the disassembly and reassembly of the HBV glycoprotein surface antigen, a pliable nanoparticle vaccine platform.
    Virology. 2017;502:176-187.
    PubMed     Text format     Abstract available


    Wkly Epidemiol Rec


  46. Status of new vaccine introduction - worldwide, September 2016.
    Wkly Epidemiol Rec. 2017;92:1-8.
    PubMed     Text format    


  47. Detection of Sabin-like type 2 poliovirus after global cessation of trivalent oral poliovirus vaccine in Hyderabad and Ahmedabad, India, August-September 2016.
    Wkly Epidemiol Rec. 2017;92:9-11.
    PubMed     Text format    


  48. Global Advisory Committee on Vaccine Safety, 30 November - 1 December 2016.
    Wkly Epidemiol Rec. 2017;92:13-20.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: